AC484 stimulates immune cells, markedly enhancing their capacity to eliminate cancer cells, and exhibits potent anticancer activity in a mouse model that shows resistance to programmed cell death protein 1 (PD‐1) inhibitors. This evidence concerns the gene PDCD1 and cancer.